Alleviant Medical

Alleviant Medical is an innovative, clinical-stage medical device company pioneering a no-implant interatrial shunt therapy for heart failure. Its core technology, the Alleviant System, is a catheter-based device that creates a small, pressure-relieving passage between the heart's atria, aiming to improve symptoms and quality of life for patients who remain symptomatic despite optimal medical therapy. The company is advancing its technology through two pivotal clinical trials and operates as a pre-revenue, private entity backed by venture capital. If successful, Alleviant's implant-free approach could differentiate it in the growing market for heart failure interventional devices.

Catheter-based system for creating an interatrial shunt without a permanent implant, designed to reduce left atrial pressure in heart failure patients.

Alleviant competes in the interatrial shunt space with companies like Corvia Medical (Atrial Shunt Device) and V-Wave (interatrial shunt, partnered with Edwards Lifesciences), which have active clinical programs and CE Marks. It also faces indirect competition from other heart failure device and pharmacotherapy companies. Its key differentiator is the lack of a permanent implant.